Skip to main content
Caplight Logo









Medipresso

Medipresso

Private
DaejeonHealthcare & Life Scienceshttps://medipresso.com/

Last Round

Crowdfunding

Nov 1, 2023

Est. Valuation

$13.4M

Total Funding Raised

$2.48M

Company Overview

Medipresso is a food-tech company that produces and sells herbal and traditional Korean tea in capsules compatible with Nespresso machines.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine, Biotech Equipment

Business Model

B2C

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

Nespresso compatible capsulesfunctional beveragesautomated compounding devicetea capsulesNespresso for medicinerazor and blade modelpersonalized medicinefood techtraditional medicine automationhealth techB2C e-commercebiotech equipmentsuperfood supplementsAI recommendations

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medipresso Comparables

Compare Medipresso with similar companies based on industry and business-model similarity.

Medipresso comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CurifyLabs
63%
Fagron
55%
Integration
52%

Medipresso Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingNov 1, 2023
Series AJun 1, 2023
VC RoundDec 7, 2021
DebtJan 21, 2021
Pre SeedFeb 6, 2020

Medipresso Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2023

    Raised $335K in a crowdfunding round.

  • Jun 1, 2023

    $1M round led by ROI Investment Partners

Medipresso Filings

Explore SEC and related filing metadata, where available.

Medipresso filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medipresso's valuation, stock price, and market status.

Is Medipresso a public or private company?

Medipresso is a private company.

What is the current stock price of Medipresso?

Medipresso is a private company with no public stock price. No recent secondary market data is available.

How much is Medipresso worth (valuation)?

Medipresso's valuation is estimated at $13.4M based on funding round data.

Can I buy Medipresso stock?

Medipresso shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medipresso's last funding round?

Medipresso's most recent funding round was Crowdfunding on November 1, 2023.

Who are the main investors in Medipresso?

Key investors in Medipresso include Seoul Business Agency, ROI Investment Partners.

Will Medipresso IPO soon?

No public IPO plans have been announced for Medipresso.

How can I track Medipresso secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medipresso's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDaejeon
Year Founded2018
Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?